First-Line Switch to B/F/TAF for Treatment of HIV in Older Adults ≥60 Years in Kenya (the B/F/TAF-Elderly Study)
Abstract
Background: Older people living with HIV (PWH) are disproportionately affected by an increasing burden of comorbidities. There are few clinical trials of switching antiretrovirals in this population, particularly in Africa.
Methods: In this open-label randomized trial, virally suppressed PWH aged ≥60 years were randomized 1:1 to switch to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) or to continue their current antiretroviral regimen (CAR) at two sites in Kenya. Participants had bone mineral density (BMD) measurement at baseline, and at weeks 24 and 48. Calcium and vitamin D supplementation was provided to all participants beginning partway through the study because of high rates of osteoporosis identified at baseline. The primary endpoints were proportion of participants with plasma HIV-1 RNA of ≥50 copies/mL at week 48 using the US Food and Drug Administration snapshot algorithm, a non-inferiority margin of 4%, and the percentage change in the lumbar spine BMD at week 48. We report the primary efficacy, BMD and safety analysis at week 48. The study is continuing to week 96.
Results: Between March and July 2022, we enrolled 520 participants with 260 randomized to switch to B/F/TAF and 260 to continue CAR and were included in intention-to-treat analysis. At week 48, 1.9% (5/260) of participants had HIV-1 RNA ≥ 50 copies/mL in the B/F/TAF arm and 2.7% (7/260) in the CAR arm (treatment difference [95% CI], -0.8% [-3.4 to 1.8]), indicating non-inferiority. Change…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 520 participants or records.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.